AcuityMD
Category: AI in Healthcare
AcuityMD raised $80 million in Series C funding, reaching a $955 million valuation to expand its AI-powered sales optimization platform for the medical technology sector. AcuityMD was founded in 2019. The company is led by Michael Monovoukas. Based in Boston, MA, USA. Total funding raised: $163 million. Latest round: Series C. Key investors include StepStone Group, Benchmark, Redpoint Ventures, ICONIQ, Atreides Management.
- Founded
- 2019
- Headquarters
- Boston, MA, USA
- Total funding
- $163 million
Value proposition
AcuityMD is the MedTech intelligence platform that combines precise data, AI-powered insights, and intuitive workflows to help medical device sales teams identify opportunities and win more deals.
Products and solutions
AcuityMD MedTech Intelligence, AcuityAI
Target customer
MedTech commercial teams (sales, marketing, market access) at medical device companies
Industries served
Medical Technology, Healthcare
Technology advantage
Purpose-built AI platform with proprietary MedTech ontology and HCP procedure data, delivering context-aware insights for the regulated medical device industry.
How they differentiate
AcuityMD uses a purpose-built AI platform with a proprietary MedTech ontology and HCP procedure data, delivering context-aware insights specifically for the regulated medical device industry.
Main competitors
MedScout, Definitive Healthcare, Alpha Sophia, IQVIA
Key partnerships
StepStone Group, ICONIQ, Atreides Management
Notable customers
16 of the top 20 MedTech companies, Kuros Biosciences, Aerin Medical, AnX Robotica, Route 92 Medical, Corza Biosurgery, Intellijoint Surgical, Pristine Surgical
Major milestones
AcuityMD raised $80 million in Series C funding, reaching a $955 million valuation to expand its AI-powered sales optimization platform for the medical technology sector., Raised $80 million in Series C funding at a $955 million valuation, Launched AcuityAI in open beta, Trusted by nearly 500 MedTech companies, Named to Forbes' 2025 'Next Billion-Dollar Startups' list, Raised $45 million in Series B funding led by Iconiq Growth (2024), Raised $31 million in Series A funding led by Redpoint (2021)
Market positioning
AcuityMD raised $80 million in Series C funding, reaching a $955 million valuation to expand its AI-powered sales optimization platform for the medical technology sector.
About Michael Monovoukas
Prior to AcuityMD, Michael was a MedTech entrepreneur and held a leadership role at PatientPing. He also worked at Bain & Company and the Federal Reserve Bank of Boston.
Official website: https://www.acuitymd.com